{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["HNSCC", "TME", "bitter melon"]], "OtherID": [], "CitationSubset": ["IM"], "InvestigatorList": [], "SpaceFlightMission": [], "GeneralNote": [], "OtherAbstract": [], "PMID": "27120805", "DateCompleted": {"Year": "2017", "Month": "12", "Day": "18"}, "DateRevised": {"Year": "2022", "Month": "04", "Day": "08"}, "Article": {"ArticleDate": [], "ELocationID": ["10.18632/oncotarget.8898"], "Language": ["eng"], "Journal": {"ISSN": "1949-2553", "JournalIssue": {"Volume": "7", "Issue": "22", "PubDate": {"Year": "2016", "Month": "May", "Day": "31"}}, "Title": "Oncotarget", "ISOAbbreviation": "Oncotarget"}, "ArticleTitle": "Immunomodulatory role of bitter melon extract in inhibition of head and neck squamous cell carcinoma growth.", "Pagination": {"StartPage": "33202", "EndPage": "33209", "MedlinePgn": "33202-9"}, "Abstract": {"AbstractText": ["Head and neck squamous cell carcinoma (HNSCC) is the sixth most common cancer and leading cause of cancer related mortality worldwide. Despite the advancement in treatment procedures the overall survival rate of patients has not considerably enhanced in the past few decades. Therefore, new strategies to achieve a favorable response for the improvement in the prognosis of HNSCC are urgently needed. In this study, we examined the role of bitter melon extract (BME) in HNSCC tumor microenvironment. Mouse head and neck cancer (SCCVII) cells were subcutaneously injected into the flanks of syngeneic mice. We observed that oral gavage of BME significantly inhibits the tumor growth in mice as compared to control group. Further study suggested that BME inhibits cell proliferation as evident from low expression of proliferating cell nuclear antigen (PCNA) and c-Myc in the tumors of BME fed mice as compared to that of control group. We next investigated the role of BME as an immunomodulator in HNSCC model. Forkhead box protein P3+ (FoxP3+) T cells suppress tumor immunity. Our data suggested that BME treatment decreases the infiltrating regulatory T (Treg) cells by inhibiting FoxP3+ populations in the tumors and in spleens. Additionally, BME treatment reduces Th17 cell population in the tumor. However, BME treatment did not alter Th1 and Th2 cell populations. Together, our findings offer a new insight into how bitter melon extract inhibits head and neck tumor growth by modulating cell proliferation and Treg populations, with implications for how to control tumor-infiltrating lymphocytes and tumor progression."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pathology, Saint Louis University, Saint Louis, Missouri, USA."}], "LastName": "Bhattacharya", "ForeName": "Sourav", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pathology, Saint Louis University, Saint Louis, Missouri, USA."}], "LastName": "Muhammad", "ForeName": "Naoshad", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pathology, Saint Louis University, Saint Louis, Missouri, USA."}], "LastName": "Steele", "ForeName": "Robert", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Internal Medicine, Saint Louis University, Saint Louis, Missouri, USA."}], "LastName": "Peng", "ForeName": "Guangyong", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pathology, Saint Louis University, Saint Louis, Missouri, USA."}, {"Identifier": [], "Affiliation": "Department of Internal Medicine, Saint Louis University, Saint Louis, Missouri, USA."}], "LastName": "Ray", "ForeName": "Ratna B", "Initials": "RB"}], "GrantList": [{"GrantID": "R01 DE025141", "Acronym": "DE", "Agency": "NIDCR NIH HHS", "Country": "United States"}, {"GrantID": "R21 CA198382", "Acronym": "CA", "Agency": "NCI NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Oncotarget", "NlmUniqueID": "101532965", "ISSNLinking": "1949-2553"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents, Immunological"}, {"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents, Phytogenic"}, {"RegistryNumber": "0", "NameOfSubstance": "Forkhead Transcription Factors"}, {"RegistryNumber": "0", "NameOfSubstance": "Foxp3 protein, mouse"}, {"RegistryNumber": "0", "NameOfSubstance": "Myc protein, mouse"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "0", "NameOfSubstance": "Proliferating Cell Nuclear Antigen"}, {"RegistryNumber": "0", "NameOfSubstance": "Proto-Oncogene Proteins c-myc"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Antineoplastic Agents, Immunological"}, {"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Antineoplastic Agents, Phytogenic"}, {"QualifierName": ["drug therapy", "immunology", "metabolism", "pathology"], "DescriptorName": "Carcinoma, Squamous Cell"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Proliferation"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["metabolism"], "DescriptorName": "Forkhead Transcription Factors"}, {"QualifierName": ["drug therapy", "immunology", "metabolism", "pathology"], "DescriptorName": "Head and Neck Neoplasms"}, {"QualifierName": ["drug effects", "immunology", "metabolism"], "DescriptorName": "Lymphocytes, Tumor-Infiltrating"}, {"QualifierName": [], "DescriptorName": "Mice, Inbred C3H"}, {"QualifierName": ["chemistry"], "DescriptorName": "Momordica charantia"}, {"QualifierName": [], "DescriptorName": "Phytotherapy"}, {"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Plant Extracts"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["metabolism"], "DescriptorName": "Proliferating Cell Nuclear Antigen"}, {"QualifierName": ["metabolism"], "DescriptorName": "Proto-Oncogene Proteins c-myc"}, {"QualifierName": ["drug effects"], "DescriptorName": "Signal Transduction"}, {"QualifierName": [], "DescriptorName": "Squamous Cell Carcinoma of Head and Neck"}, {"QualifierName": ["drug effects", "immunology", "metabolism"], "DescriptorName": "T-Lymphocytes, Regulatory"}, {"QualifierName": [], "DescriptorName": "Time Factors"}, {"QualifierName": ["drug effects"], "DescriptorName": "Tumor Burden"}, {"QualifierName": [], "DescriptorName": "Tumor Escape"}, {"QualifierName": [], "DescriptorName": "Tumor Microenvironment"}], "CoiStatement": "The authors declare no potential conflicts of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Nerurkar P, Ray RB. Bitter melon: antagonist to cancer. Pharm Res. 2010;27:1049\u201353.", "ArticleIdList": ["20198408"]}, {"Citation": "Boeing H, Bechthold A, Bub A, Ellinger S, Haller D, Kroke A, Leschik-Bonnet E, M\u00fcller MJ, Oberritter H, Schulze M, Stehle P, Watzl B. Critical review: vegetables and fruit in the prevention of chronic diseases. Eur J Nutr. 2012;51:637\u201363.", "ArticleIdList": ["PMC3419346", "22684631"]}, {"Citation": "Rajamoorthi A, Shrivastava S, Steele R, Nerurkar P, Gonzalez JG, Crawford S, Varvares M, Ray RB. Bitter melon reduces head and neck squamous cell carcinoma growth by targeting c-Met signaling. PLoS One. 2013;17(8):e78006.", "ArticleIdList": ["PMC3798549", "24147107"]}, {"Citation": "Croci DO, ZacariasFluck MF, Rico MJ, Matar P, Rabinovich GA, Scharovsky OG. Dynamic cross-talk between tumor and immune cells in orchestrating the immunosuppressive network at the tumor microenvironment. Cancer Immunol Immunother. 2007;56:1687\u2013700.", "ArticleIdList": ["17571260"]}, {"Citation": "Whiteside TL. The tumor microenvironment and its role in promoting tumor growth. Oncogene. 2008;27:5904\u201312.", "ArticleIdList": ["PMC3689267", "18836471"]}, {"Citation": "Jie HB, Gildener-Leapman N, Li J, Srivastava RM, Gibson SP, Whiteside TL, Ferris RL. Intratumoral regulatory T cells upregulate immunosuppressive molecules in head and neck cancer patients. Br J Cancer. 2013;109:2629\u201335.", "ArticleIdList": ["PMC3833228", "24169351"]}, {"Citation": "Curiel TJ. Regulatory T cells and treatment of cancer. Curr Opin Immunol. 2008;20:241\u20136.", "ArticleIdList": ["PMC3319305", "18508251"]}, {"Citation": "Caspi RR. Immunotherapy of autoimmunity and cancer: the penalty for success. Nat Rev Immunol. 2008;8:970\u20136.", "ArticleIdList": ["PMC2764117", "19008897"]}, {"Citation": "Aravindaram K, Yang NS. Anti-inflammatory plant natural products for cancer therapy. Planta Med. 2010;76:1103\u201317.", "ArticleIdList": ["20432202"]}, {"Citation": "Ru P, Steele R, Nerurkar PV, Phillips N, Ray RB. Bitter melon extract impairs prostate cancer cell-cycle progression and delays prostatic intraepithelial neoplasia in TRAMP model. Cancer Prev Res (Phila) 2011;4:2122\u201330.", "ArticleIdList": ["PMC3232292", "21911444"]}, {"Citation": "Albini A, Sporn MB. The tumour microenvironment as a target for chemoprevention. Nat Rev Cancer. 2007;7:139\u2013147.", "ArticleIdList": ["17218951"]}, {"Citation": "Bailey SR, Nelson MH, Himes RA, Li Z, Mehrotra S, Paulos CM. Th17 cells in cancer: the ultimate identity crisis. Front Immunol. 2014;17(5):276.", "ArticleIdList": ["PMC4060300", "24987392"]}, {"Citation": "Hanahan D, Coussens LM. Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell. 2012;21:309\u201322.", "ArticleIdList": ["22439926"]}, {"Citation": "Wang SC. PCNA: a silent housekeeper or a potential therapeutic target? Trends Pharmacol Sci. 2014;35:178\u201386.", "ArticleIdList": ["24655521"]}, {"Citation": "Gabay M, Li Y, Felsher DW. MYC activation is a hallmark of cancer initiation and maintenance. Cold Spring Harb Perspect Med. 2014;4 pii: a014241.", "ArticleIdList": ["PMC4031954", "24890832"]}, {"Citation": "Liu C, Workman CJ, Vignali DA. Targeting Regulatory T Cells in Tumors. FEBS J. 2016 doi: 10.1111/febs.13656.", "ArticleIdList": ["10.1111/febs.13656", "26787424"]}, {"Citation": "Campbell DJ, Koch MA. Phenotypical and functional specialization of FOXP3+ regulatory T cells. Nat Rev Immunol. 2011;11:119\u201330.", "ArticleIdList": ["PMC3289970", "21267013"]}, {"Citation": "Young MR, Levingston CA, Johnson SD. Treatment to sustain a Th17-type phenotype to prevent skewing toward Treg and to limit premalignant lesion progression to cancer. Int J Cancer. 2016 doi: 10.1002/ijc.29989.", "ArticleIdList": ["10.1002/ijc.29989", "PMC5925421", "26756968"]}, {"Citation": "Mohammed J, Ryscavage A, Perez-Lorenzo R, Gunderson AJ, Blazanin N, Glick AB. TGFbeta1-induced inflammation in premalignant epidermal squamous lesions requires IL-17. J Invest Dermatol. 2010;130:2295\u2013303.", "ArticleIdList": ["20410912"]}, {"Citation": "Lanca T, Silva-Santos B. The split nature of tumor-infiltrating leukocytes: implications for cancer surveillance and immunotherapy. Oncoimmunology. 2012;1:717\u20132510.", "ArticleIdList": ["PMC3429575", "22934263"]}, {"Citation": "Dai Y, Jiao H, Teng G, Wang W, Zhang R, Wang Y, Hebbard L, George J, Qiao L. Embelin reduces colitis-associated tumorigenesis through limiting IL-6/STAT3 signaling. Mol Cancer Ther. 2014;13:1206\u20131610.", "ArticleIdList": ["24651526"]}, {"Citation": "Ray RB, Raychoudhuri A, Steele R, Nerurkar P. Bitter melon (Momordica charantia) extract inhibits breast cancer cell proliferation by modulating cell cycle regulatory genes and promotes apoptosis. Cancer Res. 2010;70:1925\u20131931.", "ArticleIdList": ["20179194"]}], "ReferenceList": []}], "History": [{"Year": "2016", "Month": "2", "Day": "20"}, {"Year": "2016", "Month": "4", "Day": "10"}, {"Year": "2016", "Month": "4", "Day": "28", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "4", "Day": "28", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "12", "Day": "19", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "5", "Day": "31"}], "PublicationStatus": "ppublish", "ArticleIdList": ["27120805", "PMC5078086", "10.18632/oncotarget.8898", "8898"]}}], "PubmedBookArticle": []}